Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells
Author(s) -
Kazuto Harada,
Madhavi Patnana,
Xuemei Wang,
Masaaki Iwatsuki,
Mariela A. Blum Murphy,
Meina Zhao,
Prajnan Das,
Bruce D. Minsky,
Brian Weston,
Jeffrey H. Lee,
Manoop S. Bhutani,
Jeannelyn S. Estrella,
Namita Shanbhag,
Naruhiko Ikoma,
Brian D. Badgwell,
Jaffer A. Ajani
Publication year - 2020
Publication title -
surgery today
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 63
eISSN - 1436-2813
pISSN - 0941-1291
DOI - 10.1007/s00595-020-02018-2
Subject(s) - medicine , signet ring cell , surgical oncology , adenocarcinoma , signet ring cell carcinoma , oncology , gastroenterology , cancer , general surgery
Preoperative chemoradiation is a potential treatment option for localized gastric adenocarcinoma (GAC). Currently, the response to chemoradiation cannot be predicted. We analyzed the pretreatment maximum standardized uptake value (SUV max ) and total lesion glycolysis (TLG) on positron emission tomography/computed tomography as potential predictors of the response to chemoradiation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom